Wound Care - Egypt

  • Egypt
  • Revenue in the Wound Care market amounts to US$1.52m in 2024. The market is expected to grow annually by 1.16% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,052m in 2024).
  • In relation to total population figures, per person revenues of US$0.01 are generated in 2024.

Key regions: Philippines, India, Europe, United States, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Egypt is experiencing significant growth and development due to various factors.

Customer preferences:
In Egypt, customers have a strong preference for advanced wound care products that offer effective and efficient healing. They are increasingly seeking products that can accelerate the wound healing process and minimize scarring. Customers also value products that are easy to use and provide pain relief. Additionally, there is a growing demand for wound care products that are cost-effective and accessible to a wide range of patients.

Trends in the market:
One of the key trends in the Wound Care market in Egypt is the increasing adoption of advanced wound care products. This includes products such as hydrogels, foam dressings, and antimicrobial dressings, which are designed to promote faster healing and prevent infections. The demand for these products is driven by the rising awareness among healthcare professionals and patients about their benefits. Moreover, the growing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is also contributing to the demand for advanced wound care products. Another trend in the market is the shift towards home-based wound care. With the increasing availability of wound care products that are easy to use and require minimal medical supervision, more patients are opting to manage their wounds at home. This trend is driven by the desire for convenience and cost savings, as well as the need to reduce the burden on healthcare facilities. As a result, there is a growing demand for wound care products that are suitable for self-administration and can provide effective healing outcomes outside of a clinical setting.

Local special circumstances:
Egypt has a large population, with a significant portion of the population being affected by chronic diseases such as diabetes. This has led to a high prevalence of chronic wounds, which require specialized wound care products for effective management. Additionally, the country has a growing elderly population, who are more prone to developing wounds and require specialized care. These local circumstances contribute to the demand for wound care products in Egypt.

Underlying macroeconomic factors:
The Wound Care market in Egypt is also influenced by underlying macroeconomic factors. The country has been experiencing economic growth in recent years, which has led to an increase in healthcare expenditure. This has resulted in improved healthcare infrastructure and access to medical services, including wound care. Furthermore, the government has been actively promoting healthcare initiatives and investing in the development of the healthcare sector, which has further contributed to the growth of the Wound Care market. In conclusion, the Wound Care market in Egypt is witnessing growth and development due to customer preferences for advanced wound care products, the increasing adoption of these products, the shift towards home-based wound care, local special circumstances such as a high prevalence of chronic wounds, and underlying macroeconomic factors such as economic growth and government initiatives.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)